Benzinga - Tue, 23 Feb 2021 17:37:20 -0400
Benzinga - Fri, 19 Feb 2021 17:46:35 -0400
Benzinga - Tue, 16 Feb 2021 09:27:28 -0400
Benzinga - Mon, 15 Feb 2021 12:40:13 -0400
Benzinga - Thu, 11 Feb 2021 15:08:57 -0400
Benzinga - Thu, 11 Feb 2021 12:16:41 -0400
Benzinga - Thu, 11 Feb 2021 10:42:21 -0400
Benzinga - Thu, 11 Feb 2021 10:41:16 -0400
load more
Sector: Health Care.Industry: Biotechnology
Monopar Therapeutics Inc is the United States-based clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to improve clinical outcomes for cancer patients. Its pipeline products comprise of Validive, Camsirubicin, and MNPR-101.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-06
REV
Q4 2020Est.ActualSurprise
EPS
(EXPECTED)2021-03-26
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
MNPRMonopar Therapeutics-4.52%84.6M

Monopar Therapeutics Company Questions & Answers

Q

How do I buy Monopar Therapeutics (MNPR) stock?

A

You can purchase shares of Monopar Therapeutics (NASDAQ: MNPR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Monopar Therapeutics's (MNPR) main competitors?

A

Other companies in Monopar Therapeutics’s space includes: PolarityTE (NASDAQ:PTE), Cleveland BioLabs (NASDAQ:CBLI) and Biocept (NASDAQ:BIOC).

Q

What is the target price for Monopar Therapeutics?

A

The latest price target for Monopar Therapeutics (NASDAQ: MNPR) was reported by Roth Capital on 2021-01-28. The analyst firm set a price target for 49.00 expecting MNPR to rise to within 12 months (a possible 563.06% upside). 2 analyst firms have reported ratings in the last year.

Q

How much is Monopar Therapeutics (MNPR) stock ?

A

The stock price for Monopar Therapeutics (NASDAQ: MNPR) is $7.39 last updated Thu Feb 25 2021 21:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Monopar Therapeutics (MNPR) dividend?

A

There are no upcoming dividends for Monopar Therapeutics.

Q

When is Monopar Therapeutics (NASDAQ:MNPR) reporting earnings?

A
Monopar Therapeutics’s Q1 earnings are confirmed after-market from now on May 6, 2021.
Q

When is the upcoming split for MNPR?

A

There is no upcoming split for Monopar Therapeutics.